Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New agents for HIV identified at Parker Hughes Institute

June 21, 2002

InNexus acquires SAT rights to 1F7

June 17, 2002

Continued expression of anti-HIV-1 antisense RNA up to 24 months after HGTV-43 gene therapy

June 17, 2002

Novel HIV RT inhibitors identified at Parker Hughes Institute

June 13, 2002

Novel reverse transcriptase inhibitors presented by Roche

June 10, 2002

MIV-310 produces reduction in viral load in multidrug-resistant HIV patients

June 6, 2002

HIV integrase inhibitors in early development at Merck & Co.

June 6, 2002

HIV immune responses induced by Remune plus CpG adjuvant in monkeys

June 3, 2002

Investigational HIV protease inhibitor submitted for review in Europe by BMS

May 31, 2002

Euroscreen licenses CCR5 to Pfizer

May 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...